Your browser doesn't support javascript.
loading
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer.
Maltoni, Roberta; Bravaccini, Sara.
Affiliation
  • Maltoni R; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Bravaccini S; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Ann Transl Med ; 10(7): 389, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35530936
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Transl Med Year: 2022 Document type: Article Affiliation country: Italy Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Transl Med Year: 2022 Document type: Article Affiliation country: Italy Country of publication: China